Cactus extract tested as last hope for untreatable cancer pain
NCT ID NCT00804154
Summary
This early-stage study is testing the safety of an experimental drug called resiniferatoxin (RTX) for people with severe pain from advanced cancer that other treatments cannot control. RTX is derived from a cactus-like plant and works by targeting and destroying the nerves that send pain signals. The drug is injected directly into the fluid around the spinal cord, and researchers will carefully monitor 45 participants to find a safe and effective dose.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACTABLE PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.